Cargando…

Alleviative effects of fluoxetine on depressive-like behaviors by epigenetic regulation of BDNF gene transcription in mouse model of post-stroke depression

Fluoxetine, one of the selective serotonin reuptake inhibitor (SSRI) antidepressants, has been thought to be effective for treating post-stroke depression (PSD). Recent work has shown that fluoxetine may exert an antidepressive effect through increasing the level of brain-derived neurotrophic factor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Hui-Juan, Pei, Lei, Li, Ya-Nan, Zheng, Hui, Yang, Shuai, Wan, Yan, Mao, Ling, Xia, Yuan-Peng, He, Quan-Wei, Li, Man, Yue, Zhen-Yu, Hu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668242/ https://www.ncbi.nlm.nih.gov/pubmed/29097744 http://dx.doi.org/10.1038/s41598-017-13929-5

Ejemplares similares

The effects of Xingnao Jieyu capsules on post-stroke depression are similar to those of fluoxetine
por: Yan, Yongmei, et al.
Publicado: (2013)

Association Between MKP-1, BDNF, and Gonadal Hormones with Depression on Perimenopausal Women
por: Hui, Ling-yun, et al.
Publicado: (2016)

Olanzapine and fluoxetine combination in severe or resistant depression
por: Haridas, R.M., et al.
Publicado: (2003)

Treatment of depression in older adults beyond fluoxetine
por: Wagner, Gabriela Arantes
Publicado: (2015)

Does fluoxetine reduce apathetic and depressive symptoms after stroke? An analysis of the Efficacy oF Fluoxetine—a randomized Controlled Trial in Stroke trial data set
por: Tay, Jonathan, et al.
Publicado: (2022)

Effect of Fluoxetine on Some Cognitive Functions of Patients of Depression
por: Jaykaran,, et al.
Publicado: (2009)

Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression
por: Santos, Tainaê, et al.
Publicado: (2012)

Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression
por: Zahrai, Amin, et al.
Publicado: (2020)

Electroacupuncture Alleviates Depressive-Like Symptoms and Modulates BDNF Signaling in 6-Hydroxydopamine Rats
por: Sun, Min, et al.
Publicado: (2016)

The functions of fluoxetine and identification of fluoxetine-mediated circular RNAs and messenger RNAs in cerebral ischemic stroke
por: He, Yitao, et al.
Publicado: (2021)

The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF
por: Scabia, Gaia, et al.
Publicado: (2018)

Alterations of Serum Levels of BDNF-Related miRNAs in Patients with Depression
por: Li, You-Jie, et al.
Publicado: (2013)

Risk of prenatal depression and stress treatment: alteration on serotonin system of offspring through exposure to Fluoxetine
por: Pei, Siran, et al.
Publicado: (2016)

Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder
por: Shkundin, Anton, et al.
Publicado: (2023)

Ketamine Alleviates Postoperative Depression-Like Symptoms in Susceptible Mice: The Role of BDNF-TrkB Signaling
por: Li, Shan, et al.
Publicado: (2020)

Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression
por: Chavda, Nilesh, et al.
Publicado: (2011)

Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression
por: Du, Ren-Hong, et al.
Publicado: (2016)

Serum levels of chemokines in adolescents with major depression treated with fluoxetine
por: de la Peña, Francisco Rafael, et al.
Publicado: (2020)

Acute neural effects of fluoxetine on emotional regulation in depressed adolescents
por: Capitão, Liliana P., et al.
Publicado: (2023)

Erratum: Risk of prenatal depression and stress treatment: alteration on serotonin system of offspring through exposure to Fluoxetine
por: Pei, Siran, et al.
Publicado: (2017)

The Role of BDNF on Neural Plasticity in Depression
por: Yang, Tao, et al.
Publicado: (2020)

Fluoxetine ameliorates depressive symptoms by regulating lncRNA expression in the mouse hippocampus
por: Zhang, Chuan-Ling, et al.
Publicado: (2021)

Herba Rhodiolae alleviates depression via the BDNF/TrkB-GSK-3β signaling pathway
por: Gao, Lili, et al.
Publicado: (2021)

Necroptotic kinases are involved in the reduction of depression-induced astrocytes and fluoxetine’s inhibitory effects on necroptotic kinases
por: Zeb, Salman, et al.
Publicado: (2023)

Anti-Depressant Fluoxetine Reveals its Therapeutic Effect Via Astrocytes
por: Kinoshita, Manao, et al.
Publicado: (2018)

Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine
por: Yang, Wei-Cheng, et al.
Publicado: (2017)

Antidepressant effects of Kai-Xin-San in fluoxetine-resistant depression rats
por: Dong, X.Z., et al.
Publicado: (2017)

6-Sulfatoxymelatonin predicts treatment response to fluoxetine in major depressive disorder
por: Jury Freitas, Juliana, et al.
Publicado: (2019)

Can Fluoxetine Combined with Cognitive Behavioral Therapy Reduce the Suicide and Non-Suicidal Self-Injury Incidence and Recurrence Rate in Depressed Adolescents Compared with Fluoxetine Alone? A Meta-Analysis
por: Liu, Wenliang, et al.
Publicado: (2022)

ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis
por: Lin, Ching-Hua, et al.
Publicado: (2017)

Serum NLRP3 Inflammasome and BDNF: Potential Biomarkers Differentiating Reactive and Endogenous Depression
por: Yang, Xin-Jing, et al.
Publicado: (2022)

A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study
por: Wu, Ruyan, et al.
Publicado: (2015)

BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
por: Fonseca, Francina, et al.
Publicado: (2022)

Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
por: Brunner, Elizabeth, et al.
Publicado: (2014)

Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment
por: Alboni, S, et al.
Publicado: (2017)

5-HT(4) Receptors Are Not Involved in the Effects of Fluoxetine in the Corticosterone Model of Depression
por: Amigo, Josep, et al.
Publicado: (2021)

Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan, Shuxin, et al.
Publicado: (2017)

Epigenetics and depression 
por: Penner-Goeke, Signe, et al.
Publicado: (2019)

Estrogen administration attenuates post-stroke depression by enhancing CREB/BDNF/TrkB signaling in the rat hippocampus
por: Jiang, Huigang, et al.
Publicado: (2021)

Beneficial effect of fluoxetine treatment aganist psychological stress is mediated by increasing BDNF expression in selected brain areas
por: Li, Gongying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t80n11gv2olk7d3c8hvvmd473q